Pure Red Cell Aplasia Following Major ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation;
主要ABO血型不合异基因造血干细胞移植后纯红再障
Methods The red cell antibodies were removed by DFPP in 5 recipients to prevent hemolysis and pure red cell aplasia following major ABO-incompatible unrelated bone marrow transplantation.